Uønskede lægemiddelreaktioner, eksklusiv laboratorieabnormaliteter, som indberettedes hos ≥ 5% af patienter i kliniske forsøg med SPRYCEL vises i Tabel 3:
Adverse drug reactions, excluding laboratory abnormalities, that were reported in ≥ 5% of patients in SPRYCEL clinical trials are shown in Table 3: